91 related articles for article (PubMed ID: 16955086)
1. Can a point-of-care urine protein assay monitor bladder cancer recurrence?
O'donnell MA
Nat Clin Pract Oncol; 2006 Sep; 3(9):482-3. PubMed ID: 16955086
[No Abstract] [Full Text] [Related]
2. Urinary bladder tumor markers.
Lokeshwar VB; Selzer MG
Urol Oncol; 2006; 24(6):528-37. PubMed ID: 17138134
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-6/10 ratio as a prognostic marker of recurrence in patients with intermediate risk urothelial bladder carcinoma.
Cai T; Mazzoli S; Meacci F; Tinacci G; Nesi G; Zini E; Bartoletti R
J Urol; 2007 Nov; 178(5):1906-11;discussion 1911-2. PubMed ID: 17868727
[TBL] [Abstract][Full Text] [Related]
4. Urine detection of survivin and diagnosis of bladder cancer.
Moore M
J Insur Med; 2001; 33(2):202-3. PubMed ID: 11510521
[No Abstract] [Full Text] [Related]
5. Urinary cytology and quantitative BTA and UBC tests in surveillance of patients with pTapT1 bladder urothelial carcinoma.
Babjuk M; Soukup V; Pesl M; Kostírová M; Drncová E; Smolová H; Szakacsová M; Getzenberg R; Pavlík I; Dvorácek J
Urology; 2008 Apr; 71(4):718-22. PubMed ID: 18387400
[TBL] [Abstract][Full Text] [Related]
6. Urine test boosts detection of recurrent bladder cancer.
Hilton L
RN; 2006 Apr; 69(4):3-4. PubMed ID: 16640017
[No Abstract] [Full Text] [Related]
7. Considerations on the use of urine markers for bladder cancer.
van Rhijn BW
Eur Urol; 2008 May; 53(5):880-1. PubMed ID: 18222604
[No Abstract] [Full Text] [Related]
8. Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
Hutterer GC; Karakiewicz PI; Zippe C; Lüdecke G; Boman H; Sanchez-Carbayo M; Casella R; Mian C; Friedrich MG; Eissa S; Akaza H; Serretta V; Hedelin H; Rupesh R; Miyanaga N; Sagalowsky AI; Perrotte P; Lotan Y; Marberger MJ; Shariat SF
BJU Int; 2008 Mar; 101(5):561-5. PubMed ID: 18257856
[TBL] [Abstract][Full Text] [Related]
9. Quick test for recurrent bladder cancer.
Health News; 2006 Apr; 12(4):13. PubMed ID: 16583496
[No Abstract] [Full Text] [Related]
10. Potential of urinary biomarkers in early bladder cancer diagnosis.
Lam T; Nabi G
Expert Rev Anticancer Ther; 2007 Aug; 7(8):1105-15. PubMed ID: 18028019
[TBL] [Abstract][Full Text] [Related]
11. Telomerase and other novel approaches to bladder cancer detection.
Bennett A
Clin Lab Sci; 2008; 21(3):185-90; quiz 191-2, following 192. PubMed ID: 18678141
[TBL] [Abstract][Full Text] [Related]
12. The use of urine-based biomarkers in bladder cancer.
Grossman HB; Blute ML; Dinney CP; Jones JS; Liou LS; Reuter VE; Soloway MS
Urology; 2006 Mar; 67(3 Suppl 1):62-4. PubMed ID: 16530080
[No Abstract] [Full Text] [Related]
13. Secreted CXCL1 is a potential mediator and marker of the tumor invasion of bladder cancer.
Kawanishi H; Matsui Y; Ito M; Watanabe J; Takahashi T; Nishizawa K; Nishiyama H; Kamoto T; Mikami Y; Tanaka Y; Jung G; Akiyama H; Nobumasa H; Guilford P; Reeve A; Okuno Y; Tsujimoto G; Nakamura E; Ogawa O
Clin Cancer Res; 2008 May; 14(9):2579-87. PubMed ID: 18451219
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of detection of specific nuclear protein of matrix 22 in the urine in diagnosis of urinary bladder cancer].
Darenkov SP; Perlin DV; Chernyshev IV; Parshina VN; Ivanov AV; Iarovoĭ SK
Urologiia; 2006; (6):48, 49-51. PubMed ID: 17315713
[TBL] [Abstract][Full Text] [Related]
15. [Urine-based oncological diagnostic for bladder carcinoma: what is new?].
Rübben H
Urologe A; 2009 Jun; 48(6):597. PubMed ID: 19557463
[No Abstract] [Full Text] [Related]
16. Urothelial bladder cancer: biomarkers for detection and screening.
Konety B; Lotan Y
BJU Int; 2008 Nov; 102(9 Pt B):1234-41. PubMed ID: 19035887
[No Abstract] [Full Text] [Related]
17. Urinary markers for urothelial cancer.
Lane TM; Hanbury DC
BJU Int; 2004 May; 93(7):1116. PubMed ID: 15142179
[No Abstract] [Full Text] [Related]
18. Urinary CYFRA 21.1 is not a useful marker for the detection of recurrences in the follow-up of superficial bladder cancer.
Fernandez-Gomez J; Rodríguez-Martínez JJ; Barmadah SE; García Rodríguez J; Allende DM; Jalon A; Gonzalez R; Alvarez-Múgica M
Eur Urol; 2007 May; 51(5):1267-74. PubMed ID: 17207912
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of urine tumor-associated trypsin inhibitor, CYFRA 21-1, and urinary bladder cancer antigen for detection of high-grade bladder carcinoma.
Gkialas I; Papadopoulos G; Iordanidou L; Stathouros G; Tzavara C; Gregorakis A; Lykourinas M
Urology; 2008 Nov; 72(5):1159-63. PubMed ID: 18514770
[TBL] [Abstract][Full Text] [Related]
20. [Changes of urinary enzyme activity in cancer of the urinary bladder].
Nizamova RS
Vopr Onkol; 2006; 52(4):455-7. PubMed ID: 17024822
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
